First surgery using FDA-authorized Apple Vision Pro app performed at Duke Health

Overview

Updated Sep 1

An orthopedic surgeon at Duke Health performed a hip arthroscopy (keyhole surgery on the hip joint) while wearing Apple's Vision Pro headset. Stryker's SportSuite Vision software showed him the arthroscope's live video, computed tomography (CT) scans, and surgical analysis tools floating beside the patient.

The Food and Drug Administration (FDA) authorized the software on July 17, the first surgical app cleared for use with the Vision Pro during an operation. The decision created a new device category for augmented reality display systems in surgery, giving competitors a defined path to market.

Why it matters

Surgeons can now view live surgical video inside a headset, and the FDA created a regulatory pathway for augmented reality in operating rooms.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

1st

FDA-authorized surgical app for Apple Vision Pro

SportSuite Vision is the first application authorized for use during surgery with the headset.

318 days

FDA review time for the De Novo request

Stryker Endoscopy filed on September 2, 2025; the FDA authorized the device on July 17, 2026.

Completed procedures using SportSuite Vision

A hip arthroscopy at Duke Health, announced on September 1, 2026.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

People Involved

Chad Mather III, M.D., M.B.A.

Orthopedic surgeon at Duke Health who performed the first SportSuite Vision procedure

Practicing orthopedic surgeon at Duke Health

Matt Moreau

Vice president and general manager of Stryker's Sports Medicine business

Leads the division that developed SportSuite Vision

Organizations Involved

Stryker

Medical technology company

Developer of SportSuite Vision; first authorized procedure completed September 2026

Medical technology company that developed SportSuite Vision, the first surgical app authorized for Apple Vision Pro.

U.S. Food and Drug Administration

Federal regulatory agency

Granted De Novo authorization to SportSuite Vision on July 17, 2026

Federal agency that regulates medical devices and created the new device category for augmented reality displays used during surgery.

Duke Health / Duke Cancer Institute

Academic medical center

Site of the first SportSuite Vision procedure

Academic medical center in Durham, North Carolina, where the first SportSuite Vision procedure was performed.

Timeline

February 2024 September 2026

4 events Latest: September 1st, 2026 · 1 week ago

Tap a bar to jump to that date

September 2026
First surgery with SportSuite Vision completed
Latest Milestone

Chad Mather performs a hip arthroscopy at Duke Health using SportSuite Vision on Apple Vision Pro.
September 1st, 2026
July 2026
FDA authorizes SportSuite Vision
Regulatory

FDA grants De Novo authorization, creating a Class II category for augmented reality display systems used during surgery.
July 17th, 2026
September 2025
Stryker files for FDA authorization
Regulatory

Stryker Endoscopy submits De Novo request DEN250040 for SportSuite Vision, seeking first-of-its-kind classification.
September 2nd, 2025
February 2024
Apple Vision Pro launches
Product Launch

Apple's $3,499 mixed-reality headset goes on sale in the United States, bringing spatial computing to consumers.
February 2nd, 2024

Scenarios

Stryker expands SportSuite Vision beyond hip arthroscopy

Possible Resolves by Q2 2028

Discussed by: Stryker's product materials, which describe SportSuite Vision as a platform for arthroscopy surgeons across procedures

The FDA's new device category covers arthroscopic and orthopedic display systems, and Stryker markets SportSuite Vision to arthroscopy surgeons broadly. Knee and shoulder arthroscopy are far more common than hip procedures, so a new 510(k) filing claiming equivalence would reach a much larger market. Stryker has not announced a timeline.

Competitor wins FDA clearance for rival headset surgery app

Possible Resolves by Q2 2028

Discussed by: The FDA's De Novo order, which classified 'substantially equivalent devices of this generic type' into Class II, and AR industry press

The FDA's order created a generic Class II category, so any company can file a 510(k) referencing SportSuite Vision as a predicate instead of another De Novo. Orthopedic device makers with arthroscopy lines, or augmented reality startups, could build headset display apps for their own procedures. A 510(k) path is typically faster and cheaper.

SportSuite Vision adoption stalls after Duke Health launch

Uncertain Resolves by End of 2027

Discussed by: virtual.reality.news, which noted the narrow indication and the lack of disclosed clinical data or patient outcomes

The authorization covers display only, not surgical navigation or guidance, and the FDA's review relied on bench testing and cadaveric models rather than clinical trials. Stryker has not disclosed procedure length, setup requirements, or patient outcomes. Hospitals must buy headsets and train staff while the rest of the surgical team still uses traditional monitors, so adoption could remain a pilot program.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

July 2000

da Vinci robot wins FDA clearance (2000)

Intuitive Surgical's da Vinci system received FDA clearance in July 2000 for general laparoscopic surgery, becoming the first robotic platform to reach broad use in American operating rooms. Intuitive spent the next decade building surgeon training programs and hospital sales infrastructure.

Then

Hospitals adopted the robot gradually, driven by patient demand and hospital marketing as much as by clinical evidence.

Now

Robotic surgery is now routine in urology and gynecology, and Intuitive still dominates the category.

Why this matters now

The clearance was the starting gun, not the finish line. SportSuite Vision's authorization is a similarly early step whose adoption pace is unknown.

2013-2015

Google Glass in the operating room (2013-2015)

Surgeons at several academic hospitals tested Google Glass to stream procedures, view scans, and consult colleagues hands-free. The consumer headset was never built for clinical use, and the experiments ended after Google stopped selling the first-generation device in 2015.

Then

The pilots showed demand for heads-up displays in surgery but exposed problems with battery life, privacy, and durability.

Now

The failures pushed later augmented reality efforts toward purpose-built medical software and formal regulatory review.

Why this matters now

SportSuite Vision takes the opposite route: a regulated, procedure-specific app running on a commercial headset, with the FDA category Google Glass never had.

September 2018

Apple Watch ECG clearance (2018)

The FDA cleared an electrocardiogram feature on Apple Watch Series 4 in September 2018, allowing the watch to detect atrial fibrillation. The clearance came through the De Novo pathway, the same route Stryker used for SportSuite Vision.

Then

Apple marketed the ECG as a medical feature on a consumer device; cardiologists debated how useful the readings would be.

Now

The clearance opened the door to more health features on consumer wearables and established De Novo as the route for novel device-software combinations.

Why this matters now

Like the watch ECG, SportSuite Vision puts consumer hardware into a regulated medical role, with questions about clinical benefit still open.